Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

precisely: "when the science succeeds"
the problem for IP now is facing a very good chance that prurisol science may not succeed at a time when the share price is so low- any current desperation stems from this. But of course it is not desperation, since it is just another buying opportunity

and the kevetrin science is on a far horizon- let's guess, 2020 before there is a trial starting to say yes or no if it actually has ANY benefit, and 2022 before results?